Boston Scientific Launches Victory Guidewire For Crossing Resistant Lesions In Peripheral Arteries
Victory™ guidewires are designed to facilitate crossing of resistant lesions
NATICK, Mass., Oct. 9, 2012 /PRNewswire/ -- Boston Scientific Corporation has begun the United States and European launch of its Victory™ guidewire, designed to facilitate crossing of resistant lesions and the placement and exchange of balloon catheters or other interventional devices within the peripheral vasculature. The company expects to launch the product in other international markets later this year and in 2013, subject to regulatory approvals.
The Victory guidewires feature a broad matrix of high gram-load tip options ranging from 12g to 30g, designed to cross resistant lesions. A stainless steel core technology enables this wire to have superior torque for optimal steering and control. Hydrophilic coating provides enhanced lubricity to facilitate crossing resistant lesions. The Victory guidewires come in both 0.014" and 0.018" diameters with four different gram-load options offering clinical versatility and a range of pushability.